BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 17709148)

  • 1. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.
    Song JM; Park KD; Lee KH; Byun YH; Park JH; Kim SH; Kim JH; Seong BL
    Antiviral Res; 2007 Nov; 76(2):178-85. PubMed ID: 17709148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives.
    Zu M; Yang F; Zhou W; Liu A; Du G; Zheng L
    Antiviral Res; 2012 Jun; 94(3):217-24. PubMed ID: 22521753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral effect of catechins in green tea on influenza virus.
    Song JM; Lee KH; Seong BL
    Antiviral Res; 2005 Nov; 68(2):66-74. PubMed ID: 16137775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza virus susceptibility and resistance to oseltamivir.
    Aoki FY; Boivin G; Roberts N
    Antivir Ther; 2007; 12(4 Pt B):603-16. PubMed ID: 17944268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir.
    Haidari M; Ali M; Ward Casscells S; Madjid M
    Phytomedicine; 2009 Dec; 16(12):1127-36. PubMed ID: 19586764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of the antiviral effect of hydroxytyrosol on influenza virus appears to involve morphological change of the virus.
    Yamada K; Ogawa H; Hara A; Yoshida Y; Yonezawa Y; Karibe K; Nghia VB; Yoshimura H; Yamamoto Y; Yamada M; Nakamura K; Imai K
    Antiviral Res; 2009 Jul; 83(1):35-44. PubMed ID: 19501255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.
    Ilyushina NA; Bovin NV; Webster RG; Govorkova EA
    Antiviral Res; 2006 Jul; 70(3):121-31. PubMed ID: 16516984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006.
    Bauer K; Richter M; Wutzler P; Schmidtke M
    Antiviral Res; 2009 Apr; 82(1):34-41. PubMed ID: 19428593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad-spectrum antiviral effect of Agrimonia pilosa extract on influenza viruses.
    Shin WJ; Lee KH; Park MH; Seong BL
    Microbiol Immunol; 2010; 54(1):11-9. PubMed ID: 20055938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.
    Lin X; Zhou J; Zhang Y; Wu J; Zhang F; Li Z; Zhang Y; Bi S; Shu Y; Wang Y
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1305-8. PubMed ID: 19879239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand.
    Bai GR; Chittaganpitch M; Kanai Y; Li YG; Auwanit W; Ikuta K; Sawanpanyalert P
    Biochem Biophys Res Commun; 2009 Dec; 390(3):897-901. PubMed ID: 19850010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999.
    Bauer K; Schrader C; Suess J; Wutzler P; Schmidtke M
    Antiviral Res; 2007 Sep; 75(3):219-26. PubMed ID: 17445913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein.
    Cheng H; Wan J; Lin MI; Liu Y; Lu X; Liu J; Xu Y; Chen J; Tu Z; Cheng YS; Ding K
    J Med Chem; 2012 Mar; 55(5):2144-53. PubMed ID: 22332894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germacrone inhibits early stages of influenza virus infection.
    Liao Q; Qian Z; Liu R; An L; Chen X
    Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
    Yu M; Liu A; Du G; Naesens L; Vanderlinden E; De Clercq E; Liu X
    Chem Biol Drug Des; 2011 Oct; 78(4):596-602. PubMed ID: 21752202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.
    Ferraris O; Kessler N; Lina B
    Antiviral Res; 2005 Oct; 68(1):43-8. PubMed ID: 16125799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.
    Abed Y; Nehmé B; Baz M; Boivin G
    Antiviral Res; 2008 Feb; 77(2):163-6. PubMed ID: 17919743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.
    Jonges M; van der Lubben IM; Dijkstra F; Verhoef L; Koopmans M; Meijer A
    Antiviral Res; 2009 Sep; 83(3):290-7. PubMed ID: 19591877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.